<code id='C0E8271ED3'></code><style id='C0E8271ED3'></style>
    • <acronym id='C0E8271ED3'></acronym>
      <center id='C0E8271ED3'><center id='C0E8271ED3'><tfoot id='C0E8271ED3'></tfoot></center><abbr id='C0E8271ED3'><dir id='C0E8271ED3'><tfoot id='C0E8271ED3'></tfoot><noframes id='C0E8271ED3'>

    • <optgroup id='C0E8271ED3'><strike id='C0E8271ED3'><sup id='C0E8271ED3'></sup></strike><code id='C0E8271ED3'></code></optgroup>
        1. <b id='C0E8271ED3'><label id='C0E8271ED3'><select id='C0E8271ED3'><dt id='C0E8271ED3'><span id='C0E8271ED3'></span></dt></select></label></b><u id='C0E8271ED3'></u>
          <i id='C0E8271ED3'><strike id='C0E8271ED3'><tt id='C0E8271ED3'><pre id='C0E8271ED3'></pre></tt></strike></i>

          
          WSS
          In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp.
          Scott Olson/Getty Images

          WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

          The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends. 

          advertisement

          The negotiated prices won’t take effect until 2026. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          comprehensive